Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$629,299
-$71,592 QoQ
Shares Held
4,981
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,276
of 2,266 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Soltis Investment Advisors LLC holds $50,374,735 across 12 Drug Manufacturers - General names. GILD ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,990 | $12,695,960 | |
| 2 | AMGN |
Amgen Inc
|
29,172 | $10,563,764 | |
| 3 | ABBV |
AbbVie Inc.
|
35,875 | $9,027,585 | |
| 4 | LLY |
ELI LILLY & Co
|
5,809 | $6,967,489 | |
| 5 | MRK |
Merck & Co., Inc.
|
48,517 | $6,234,434 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,594 | $2,454,266 | |
| 7 | PFE |
Pfizer Inc
|
26,981 | $649,702 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
4,981 | $629,299 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $629,299 | 4,981 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $700,891 | 5,029 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $586,328 | 4,777 | Shares | Sole | 2026-04-02 | |
| 2025-09-30 | $478,410 | 4,310 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $399,132 | 3,600 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $640,141 | 5,713 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $241,639 | 2,616 | Shares | Sole | 2025-01-29 | |
| 2023-09-30 | $373,351 | 4,982 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||